Subtopic Deep Dive
KSHV-Associated Kaposi's Sarcoma Pathogenesis
Research Guide
What is KSHV-Associated Kaposi's Sarcoma Pathogenesis?
KSHV-Associated Kaposi's Sarcoma Pathogenesis is the study of molecular mechanisms by which Kaposi's sarcoma-associated herpesvirus (KSHV) drives oncogenic transformation, angiogenesis, and immune evasion in Kaposi's sarcoma tumors.
KSHV encodes viral oncogenes like G-protein-coupled receptor (vGPCR) and Latency-Associated Nuclear Antigen (LANA) that promote cell survival and vascular proliferation (Bais et al., 1998; Friborg et al., 1999). Viral microRNAs regulate host gene expression in latently infected cells (Cai et al., 2005). Over 10 key papers from 1998-2019 detail these pathways, with foundational works cited over 500 times each.
Why It Matters
KS is a leading malignancy in AIDS and transplant patients, contributing to the global burden of infection-associated cancers estimated at specific fractions worldwide (Parkin, 2006). Viral oncogenes like vGPCR drive angiogenesis, offering targets for anti-angiogenic therapies (Bais et al., 1998; Mesri et al., 2014). Understanding LANA-mediated p53 inhibition aids development of antivirals to block KSHV latency and tumor persistence (Friborg et al., 1999). These insights support precision treatments in immunocompromised populations (Cesarman et al., 2019).
Key Research Challenges
Dissecting Viral Latency Mechanisms
KSHV persists in latent infection via LANA and microRNAs, complicating antiviral targeting (Friborg et al., 1999; Cai et al., 2005). Distinguishing latency from lytic replication in tumors remains difficult. Models like Castleman disease show monotypic B cell infection, but in vivo validation lags (Du, 2001).
Quantifying Oncogenic Contributions
Viral proteins like vGPCR activate angiogenesis pathways, but host-virus interactions vary by immune status (Bais et al., 1998). Measuring contributions to hallmarks like sustained proliferation is challenging without integrated models (Mesri et al., 2014). Cytokine dysregulation via IRF7 adds complexity (Ning et al., 2011).
Developing Targeted Therapies
Immune evasion and p53 suppression hinder apoptosis induction (Friborg et al., 1999). Global cancer burden data highlight need for region-specific interventions (Parkin, 2006). Animal models underexplored for KSHV-driven KS translation to humans (Butel, 2000).
Essential Papers
The global health burden of infection‐associated cancers in the year 2002
Donald Maxwell Parkin · 2006 · International Journal of Cancer · 2.9K citations
Abstract Several infectious agents are considered to be causes of cancer in humans. The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been es...
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
Carlos Bais, Bianca Santomasso, Omar A. Coso et al. · 1998 · Nature · 836 citations
p53 inhibition by the LANA protein of KSHV protects against cell death
Jacques Friborg, Wing‐Pui Kong, Michael O. Hottiger et al. · 1999 · Nature · 705 citations
Kaposi sarcoma
Ethel Cesarman, Blossom Damania, Susan E. Krown et al. · 2019 · Nature Reviews Disease Primers · 652 citations
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Enrique A. Mesri, Mark A. Feitelson, Karl Münger · 2014 · Cell Host & Microbe · 625 citations
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells
Xuezhong Cai, Shihua Lu, Zhihong Zhang et al. · 2005 · Proceedings of the National Academy of Sciences · 582 citations
MicroRNAs (miRNAs) are an endogenously encoded class of small RNAs that have been proposed to function as key posttranscriptional regulators of gene expression in a range of eukaryotic species, inc...
IRF7: activation, regulation, modification and function
Shunbin Ning, Joseph S. Pagano, Glen N. Barber · 2011 · Genes and Immunity · 576 citations
Reading Guide
Foundational Papers
Start with Parkin (2006) for KS burden context (2917 citations), then Bais et al. (1998) for vGPCR oncogene discovery, and Friborg et al. (1999) for LANA apoptosis block—these establish core mechanisms.
Recent Advances
Cesarman et al. (2019, 652 citations) reviews clinical pathogenesis; Mesri et al. (2014, 625 citations) analyzes cancer hallmarks.
Core Methods
Core techniques: viral gene transfection for oncogenicity (Bais et al., 1998), microRNA cloning from latently infected cells (Cai et al., 2005), and monotypic B cell infection assays (Du, 2001).
How PapersFlow Helps You Research KSHV-Associated Kaposi's Sarcoma Pathogenesis
Discover & Search
Research Agent uses citationGraph on Bais et al. (1998) to map vGPCR influence across 836 citing papers, revealing angiogenesis clusters. exaSearch queries 'KSHV LANA p53 KS pathogenesis' to find 50+ related works beyond OpenAlex. findSimilarPapers on Friborg et al. (1999) uncovers LANA homologs in other viruses.
Analyze & Verify
Analysis Agent applies readPaperContent to extract vGPCR signaling from Bais et al. (1998), then verifyResponse with CoVe checks claims against Cesarman et al. (2019). runPythonAnalysis processes microRNA target networks from Cai et al. (2005) using pandas for gene ontology stats. GRADE grading scores evidence strength for LANA-p53 interaction (Friborg et al., 1999).
Synthesize & Write
Synthesis Agent detects gaps in KSHV B cell tropism post-Du (2001), flags contradictions between latency models. Writing Agent uses latexEditText to draft KS pathogenesis review, latexSyncCitations for 20 papers, and latexCompile for submission-ready PDF. exportMermaid generates pathway diagrams of vGPCR signaling.
Use Cases
"Analyze microRNA targets in KSHV latent KS cells from Cai 2005"
Analysis Agent → readPaperContent (Cai et al., 2005) → runPythonAnalysis (pandas network stats, matplotlib target plots) → researcher gets validated gene regulation CSV.
"Write LaTeX review on vGPCR oncogenesis in KS"
Synthesis Agent → gap detection (Bais 1998 + Mesri 2014) → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (10 papers) → latexCompile → researcher gets compiled PDF with figures.
"Find code for KSHV viral oncogene simulations"
Research Agent → searchPapers ('KSHV oncogene model') → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → researcher gets runnable Python sims for LANA-p53 dynamics.
Automated Workflows
Deep Research workflow scans 50+ KSHV papers via searchPapers, structures report on pathogenesis hallmarks with GRADE scores (Mesri et al., 2014). DeepScan applies 7-step CoVe to verify vGPCR claims (Bais et al., 1998) with statistical checkpoints. Theorizer generates hypotheses on microRNA-IRF7 interactions from Cai (2005) and Ning (2011).
Frequently Asked Questions
What defines KSHV-Associated Kaposi's Sarcoma Pathogenesis?
It examines how KSHV oncoproteins like vGPCR and LANA drive tumor angiogenesis, cell survival, and latency in KS (Bais et al., 1998; Friborg et al., 1999).
What are key methods in this subtopic?
Methods include viral protein functional assays, microRNA profiling in latently infected cells, and infection models of B cells and endothelium (Cai et al., 2005; Du, 2001).
What are foundational papers?
Bais et al. (1998, 836 citations) on vGPCR oncogenesis; Friborg et al. (1999, 705 citations) on LANA-p53; Parkin (2006, 2917 citations) on infection-cancer burden.
What open problems persist?
Challenges include translating latency mechanisms to therapies and modeling immune evasion in AIDS/transplant KS (Cesarman et al., 2019; Mesri et al., 2014).
Research Viral-associated cancers and disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching KSHV-Associated Kaposi's Sarcoma Pathogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers